Source apportionment of particulate matter in the U.S. and associations with lung inflammatory markers.
Size-fractionated particulate matter (PM) samples were collected from six U.S. cities and chemically analyzed as part of the Multiple Air Pollutant Study. Particles were administered to cultured lung cells and the production of three different proinflammatory markers was measured to explore the association between the health effect markers and PM. Ultrafine, fine, and coarse PM samples were collected between December 2003 and May 2004 over a 4-wk period in each city. Filters were pooled for each city and the PM samples were extracted then analyzed for trace metals, ions, and elemental carbon. Particle extracts were applied to cultured human primary airway epithelial cells, and the secreted levels of interleukin-8 (IL-8), heme oxygenase-1, and cyclooxygenase-2 were measured 1 and 24 h following exposure. Fine PM sources were quantified by the chemical mass balance (CMB) model. The relationship between toxicological measures, PM sources, and individual species were evaluated using linear regression. Ultrafine and fine PM mass were associated with increases in IL-8 (r(2) = .80 for ultrafine and r(2) = .52 for fine). Sources of fine PM and their relative contributions varied across the sampling sites and a strong linear association was observed between IL-8 and secondary sulfate from coal combustion (r(2) = .79). Ultrafine vanadium, lead, copper, and sulfate were also associated with increases in IL-8. Increases in inflammatory markers were not observed for coarse PM mass and source markers. These findings suggest that certain PM size fractions and sources are associated with markers of lung injury or inflammation.
Duvall
Rachelle M
RM
National Exposure Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. duvall.rachelle@epa.gov
Norris
Gary A
GA
Dailey
Lisa A
LA
Burke
Janet M
JM
McGee
John K
JK
Gilmour
M Ian
MI
Gordon
Terry
T
Devlin
Robert B
RB
D000393:Air Pollutants / Q000032:analysis / Q000633:toxicity*; D015415:Biomarkers / Q000378:metabolism; D002478:Cells, Cultured; D002947:Cities; D051546:Cyclooxygenase 2 / Q000235:genetics*; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism; D051547:Heme Oxygenase-1 / Q000235:genetics*; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D016209:Interleukin-8 / Q000235:genetics*; D008168:Lung / Q000166:cytology; D008670:Metals / Q000032:analysis / Q000633:toxicity; D009566:Nitrates / Q000032:analysis / Q000633:toxicity; D010316:Particle Size; D052638:Particulate Matter / Q000032:analysis / Q000633:toxicity*; D012333:RNA, Messenger / Q000378:metabolism; D013431:Sulfates / Q000032:analysis / Q000633:toxicity; D014481:United States
D000393:Air Pollutants; D015415:Biomarkers; D016209:Interleukin-8; D008670:Metals; D009566:Nitrates; D052638:Particulate Matter; D012333:RNA, Messenger; D013431:Sulfates; D051547:Heme Oxygenase-1; D051546:Cyclooxygenase 2